The researchers studied the impact new and improved new and improved anthrax vaccine, and evaluated a number of vaccines properties that start, could provide immunity between 7 and 28 days. If vaccine was distributed along with antibiotics after an attack, the researchers calculated that vaccine occurs few more cases prevented if only rapid use of antibiotics compared. However, they found, if the 95 % 95 %, it could be the time that antibiotics up up 43 days, to reduce. A new and improved 80 % effective vaccine time time on antibiotics by up to 23 days. The vaccine may also prevent cases if an antibiotic-resistant strain of anthrax were used in the attack.
In a previous phase I study, NGX267 was well tolerated in single doses probably effective for treating memory and cognitive disturbances good.. I study,ines Therapeutics Initiates Phase I Multiple Dose Clinical Trial Of NGX267 for cognitive impairment associated with schizophreniaTorreyPines Therapeutics today announced that it is a phase initiated I multiple-dose study to assess the safety, tolerability and pharmacokinetics of NGX267 when for four days for four days to healthy male volunteers. A possible treatment for cognitive impairment with schizophrenia , respectively, is a functionally selective muscarinic receptor agonist. Continue reading